Literature DB >> 3742831

Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy.

I A O'Brien, I G Lewin, J P O'Hare, J Arendt, R J Corrall.   

Abstract

The circadian rhythm of melatonin secretion from the pineal body is entrained to the light-dark cycle and is controlled via sympathetic fibres originating from the superior cervical ganglia. We have therefore examined plasma melatonin profiles in diabetics with and without evidence of autonomic neuropathy and in normal matched controls. The physiological increase in nocturnal plasma melatonin concentration was not observed in diabetics neuropaths. There was no consistent pattern in the diabetics without neuropathy; only three out of the eight subjects in this group had a sustained nocturnal increase in melatonin. Normal diurnal variation of plasma cortisol was present in all groups of subjects. The present study shows that diabetic patients with evidence of autonomic neuropathy lack the normal circadian changes of plasma melatonin concentration. This provides confirmation for the control of pineal function via the sympathetic nervous system in man. The impaired melatonin profiles observed in diabetic patients without apparent autonomic neuropathy suggest that a subclinical state of sympathetic denervation may exist in this group of diabetics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742831     DOI: 10.1111/j.1365-2265.1986.tb01639.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  20 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 2.  Circadian disruption and SCN control of energy metabolism.

Authors:  Andries Kalsbeek; Frank A Scheer; Stephanie Perreau-Lenz; Susanne E La Fleur; Chun-Xia Yi; Eric Fliers; Ruud M Buijs
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

Review 3.  Chronomedicine and type 2 diabetes: shining some light on melatonin.

Authors:  Andrew C Forrestel; Susanne U Miedlich; Michael Yurcheshen; Steven D Wittlin; Michael T Sellix
Journal:  Diabetologia       Date:  2016-12-16       Impact factor: 10.122

4.  Role of melatonin on diabetes-related metabolic disorders.

Authors:  Javier Espino; José A Pariente; Ana B Rodríguez
Journal:  World J Diabetes       Date:  2011-06-15

Review 5.  Melatonin, mitochondria, and the metabolic syndrome.

Authors:  Daniel P Cardinali; Daniel E Vigo
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

Review 6.  Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes.

Authors:  Angeliki Karamitri; Nicolas Renault; Nathalie Clement; Jean-Luc Guillaume; Ralf Jockers
Journal:  Mol Endocrinol       Date:  2013-06-24

Review 7.  Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene.

Authors:  H Mulder; C L F Nagorny; V Lyssenko; L Groop
Journal:  Diabetologia       Date:  2009-04-18       Impact factor: 10.122

Review 8.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

9.  Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men.

Authors:  Simone Mäntele; Daniella T Otway; Benita Middleton; Silvia Bretschneider; John Wright; M Denise Robertson; Debra J Skene; Jonathan D Johnston
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

10.  Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2013-03-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.